CNC Stock Overview
Operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. More details
Snowflake Score | |
---|---|
Valuation | 6/6 |
Future Growth | 1/6 |
Past Performance | 5/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Centene Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$60.83 |
52 Week High | US$81.42 |
52 Week Low | US$55.03 |
Beta | 0.46 |
1 Month Change | 1.38% |
3 Month Change | -18.44% |
1 Year Change | -17.67% |
3 Year Change | -27.57% |
5 Year Change | -1.70% |
Change since IPO | 4,143.95% |
Recent News & Updates
Recent updates
Does Centene (NYSE:CNC) Have A Healthy Balance Sheet?
Dec 05Centene: Should Have Followed My Original Thesis, But A Buy For Q3 2024
Oct 22Centene Corporation (NYSE:CNC) Screens Well But There Might Be A Catch
Oct 14Should You Be Adding Centene (NYSE:CNC) To Your Watchlist Today?
Sep 26Centene (NYSE:CNC) Has Some Way To Go To Become A Multi-Bagger
Sep 08Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly
Aug 20Centene Corporation: Strategic Market Position Amid Favorable Trends, Buy
Aug 20Centene (NYSE:CNC) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Aug 02Here's Why We Think Centene (NYSE:CNC) Is Well Worth Watching
Jun 22A Piece Of The Puzzle Missing From Centene Corporation's (NYSE:CNC) Share Price
Jun 04Returns At Centene (NYSE:CNC) Appear To Be Weighed Down
May 14These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well
Apr 26Centene Corporation Still An Opportunity With An A-Grade Valuation
Mar 31If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity
Mar 15Market Still Lacking Some Conviction On Centene Corporation (NYSE:CNC)
Feb 08Centene: Stay Defensive Amid Economic Uncertainty With This Low-Beta Bargain
Jan 22Is Centene (NYSE:CNC) Using Too Much Debt?
Jan 21Centene: Overlooked Healthcare Giant
Nov 21Centene: Solid Performance With Positive Outlook, But Limited Upside Potential
Oct 26Decoding Centene: Why I Think It's Undervalued
Oct 10Centene: Results Impress But Buyers Aren't Swarming Yet
Jul 27Centene Non-GAAP EPS of $0.86 beats by $0.02, revenue of $35.56B beats by $190M
Feb 07Centene: Once Again, With Quality, Now A 'Buy'
Dec 23Centene appoints new leadership; Ken Fasola President of Centene, Dave Thomas CEO of Medicaid
Dec 14Shareholder Returns
CNC | US Healthcare | US Market | |
---|---|---|---|
7D | 1.9% | 2.6% | -0.4% |
1Y | -17.7% | -9.4% | 24.8% |
Return vs Industry: CNC underperformed the US Healthcare industry which returned -9.4% over the past year.
Return vs Market: CNC underperformed the US Market which returned 24.8% over the past year.
Price Volatility
CNC volatility | |
---|---|
CNC Average Weekly Movement | 5.2% |
Healthcare Industry Average Movement | 7.6% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 17.0% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CNC has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: CNC's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1984 | 67,700 | Sarah London | www.centene.com |
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Centene Corporation Fundamentals Summary
CNC fundamental statistics | |
---|---|
Market cap | US$30.71b |
Earnings (TTM) | US$3.07b |
Revenue (TTM) | US$146.20b |
10.0x
P/E Ratio0.2x
P/S RatioIs CNC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CNC income statement (TTM) | |
---|---|
Revenue | US$146.20b |
Cost of Revenue | US$124.53b |
Gross Profit | US$21.67b |
Other Expenses | US$18.61b |
Earnings | US$3.07b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 04, 2025
Earnings per share (EPS) | 6.07 |
Gross Margin | 14.82% |
Net Profit Margin | 2.10% |
Debt/Equity Ratio | 64.2% |
How did CNC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/26 00:49 |
End of Day Share Price | 2024/12/24 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Centene Corporation is covered by 45 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
null null | Argus Research Company |
Hua Ha | Baird |
Ishan Majumdar | Baptista Research |